April 12, 2016 / 9:12 PM / in 2 years

BRIEF-Valeant Pharmaceuticals receives notice of default from bondholders due to delayed 10-K Filing

April 12 (Reuters) - Valeant Pharmaceuticals International Inc :

* Valeant pharmaceuticals receives notice of default from bondholders due to delayed 10-k filing

* On schedule to file its 10-k on or before april 29, 2016

* Says company has until june 11, 2016 to cure default by filing 10-k

* Notice of default does not result in acceleration of any of company’s indebtedness

* Received a notice of default from holders of its 5.5% notes due 2023 as a result of delay in company filing its form 10-k

* Says “company is on schedule to file its 10-k on or before april 29, 2016” Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below